SA Endocrine Flashcards

1
Q

Steroid hormones Action

A
  • Diffuse through cell membranes and work directly on the nucleus to regulate gene expression and resulting protein synthesis
  • Relatively stable
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Steroid hormone Examples

A
  • Aldosterone
  • Cortisol
  • Androgens
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Peptide hormones Action

A
  • Interact with cell membrane receptors and work through 2nd messenger systems
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Fragility of peptide hormones

A
  • Shorter acting

- More difficult to measure in blood

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Peptide hormone examples

A
  • Thyroxine
  • Insulin
  • ACTH
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What proportion of the pancreas is endocrine?

A
  • 2-3% of pancreatic mass
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Insulin secretion style

A
  • Pulsatile
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Insulin is released in response to what?

A
  • High blood glucose levels
  • Some amino acids
  • Intestinal hormones
  • Parasympathetic stimulation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Insulin release is inhibited by what?

A
  • Somatostatin
  • Sympathetic nervous system
  • Fasting
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Is insulin catabolic or anabolic?

A
  • Anabolic hormone
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Insulin stimulates what?

A
  1. Glycogen synthesis
  2. Lipogenesis
  3. Protein synthesis and storage
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Insulin inhibits what?

A
  1. Glycogenolysis
  2. Lipolysis
  3. Protein catabolism
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Where are insulin receptors found?

A
  • Most cells in the body
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What will up or down-regulate insulin receptors?

A
  • Levels of circulating insulin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Diabetogenic hormones

A
  1. Glucagon
  2. Growth hormone
  3. Cortisol
  4. Epinephrine and norepinephrine
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Diabetes mellitus in dogs

A
  • Combination of factors leads to irreversible beta cell destruction and lack of insulin production
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Diabetes mellitus in cats

A
  • Combination of factors (including amyloid deposition) leads to either irreversible beta cell loss or more commonly significant insulin resistance and beta cell dysfunction which can be reversible
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Acarbose Class

A
  • Alpha-glucosidase inhibitor
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Acarbose MOA

A
  • Slows post-prandial glucose absorption
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Acarbose indications

A
  • Cats that won’t eat a low carbohydrate diet
  • Dogs with poor glycemic control for which a cause cannot be found or treated
  • Not generally recommended for use, especially as a sole therapy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Adverse effects of Acarbose

A
  • Dose dependent
  • Up to 35% of patients
  • Hypoglycemia only when used with other hypoglycemic agents (insulin)
  • Dogs: diarrhea and weight loss
  • Cats: flatulence and soft stool/diarrhea
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Contraindications and cautions with Acarbose

A
  • Caution with kidney or liver disease

- Contraindicated with underweight animals, DKA, IBD/intestinal malabsorptive disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Acarbose Drug interactions

A
  • Hypoglycemic agents - may cause hypoglycemia

- Hyperglycemic agents (e.g. corticosteroids) as they may reduce or negate the effect

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Other considerations with acarbose

A
  • Not considered effective in cats with advanced kidney disease, especially with poor appetites and on low protein diets
  • Not effective in animals fed ad libitum
  • May see two weeks to see peak effect
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Glipizide class

A
  • Sulfonylurea antidiabetic agent
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Glipizide MOA

A
  • Stimulates beta cell secretion of insulin

- Must have functional beta cells for this drug to work

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Indications for use of Glipizide

A
  • Only considered useful in cats with non-insulin dependent diabetes (type II)
  • 20-30% of cats
  • If insulin cannot be given or very small doses of insulin are needed to control the DM
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Contraindications of Glipizide

A
  • DKA, acidosis, severe trauma/infection, surgery
  • Caution with untreated adrenal or pituitary insufficiency, thyroid impairment, kidney or liver disease, vomiting, fever, malnourishment
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

Adverse effects of Glipizide

A
  • GI signs: seen in 15% of cats
  • Hypoglycemia - rare, more likely when given with other hypoglycemic agents (insulin)
  • Increased amyloid deposition which can worsen beta cell function
  • Elevated liver enzymes and jaundice (8%), which should be monitored every 1-2 weeks initially
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

Drug interactions of Glipizide

A
  • Many! Either reduce or potentiate the effects

- Always check before starting

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

How long until you see an effect with glipizide?

A
  • May take 1-2 months to see effect
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

Route of administration of acarbose and glipizide

A
  • Oral
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

What are some of the drawbacks for oral hypoglycemic therapy in general?

A
  • In general, oral hypoglycemic agents are not recommended for use
  • Response to therapy is minimal: must select patients properly.
  • 15% good response (some develop resistance over time)
  • 15% partial response
  • Cats will have a better chance of going into remission if treated with insulin therapy instead
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

Insulin types

A
  • Human, porcine, and bovine (only compounded)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

Canine insulin similarity to pig, human, and bovine insulin

A
  • Canine insulin = porcine insulin
  • 1 amino acid different than human
  • 3 amino acids different from bovine
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

Feline insulin similarity to pig, human, and bovine insulin

A
  • 1 amino acid different from bovine
  • 3 amino acids different from porcine
  • 4 amino acids different from human
  • However they tend to do well with this
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

What are the four formulations of insulin and the routes?

A
  • Regular (IV, IM, OR SC)
  • NPH (SC only, never IV)
  • PZI (SC only)
  • Lente/Ultralente (SC only)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

Regular insulin

A
  • Recombinant human insulin with no chemical modification
  • Onset and duration basically the same as endogenous insulin (short onset)
  • IV, IM, or SC

ONLY ONE WE CAN GIVE IV

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

NPH Insulin

A
  • Combined with protein (protamine) to delay absorption after SC administration
  • Administered SC (never IV)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
40
Q

PZI Insulin

A
  • Combined with protamine and zinc
  • Greater delay in absorption than NPH after SC
  • Administer SC (never IV)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
41
Q

Lente/Ultralente Insulin

A
  • Insulin molecules combined into crystals of various sizes

- Small crystals (semi-lente) or large crystals (ultra-lente)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
42
Q

Difference between semi-lente and ultralente for absorption

A
  • Smaller crystals delay absorption for a short time

- Larger crystals result in longer delay

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
43
Q

Lente combination

A
  • Lente is combo of 30% semi-lente crystals and 70% lente crystals
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
44
Q

Lente route

A
  • SC
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
45
Q

Synthetic insulins/insulin analogs

A
  • Basically human insulins
  • Chemical modification of human insulin structures
  • Amino acids added, substituted, modified
  • Altered structure slows absorption and degradation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
46
Q

Adverse effects of insulin in general

A
  • HYPOGLYCEMIA
  • Somogyi effect (insulin induced hyperglycemia)
  • Injection site reactions
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
47
Q

Drug interactions with insulin

A
  • Many! May potentiate or decrease hypoglycemic effects

- Always check Plumbs before starting

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
48
Q

Humulin R/Novalin R

A
  • Recombinant Human Insulin

- Insulin of choice for DKA, hyperkalemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
49
Q

Duration of Humulin R/Novalin R

A
  • Short acting
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
50
Q

Route of Humulin R/Novalin R

A
  • Can be given IV or IM
51
Q

Indications for Humulin R/Novalin R

A
  • DKA
  • Urethral obstruction with high potassium
  • In those cats they often give with dextrose to drive potassium into the cells
52
Q

Considerations for Humulin R/Novalin R

A
  • Refrigerate

- Do not shake bottle but role gently to mix

53
Q

Vetsulin

A
  • Porcine Lente Insulin
54
Q

Vetsulin indication

A
  • Insulin of choice for dogs
55
Q

Vetsulin duration of action

A
  • Generally about 12 hours
56
Q

What type of syringe do you use with vetsulin?

A

U-40!

57
Q

Dosing frequency and route for Vetsulin

A
  • BID

- SC with meals

58
Q

Other considerations for vetsulin

A
  • Refrigerate

- Shake thoroughly before drawing up**** (THE ONLY ONE YOU SHAKE)

59
Q

Novolin-N, Humulin-N

A
  • NPH insulin, human recombinant
60
Q

Indication for Novolin-N, Humulin-N

A
  • Commonly used insulin for dogs if Vetsulin is not an option
61
Q

Duration of Novolin-N, Humulin-N

A
  • Intermediate acting
62
Q

Dose frequency and Route for Novolin-N and Humulin-N

A
  • BID
  • SC with meals
  • Use U-100 syringes
63
Q

Novolin-N and Humulin-N other considerations

A
  • Refrigerate

- Do not shake the bottle - roll gently to mix

64
Q

Levemir/Detemir

A
  • Human recombinant insulin analog
65
Q

Indication for levemir/detemir

A
  • More potent - canine insulin receptors 4x more sensitive to detemir than humans
66
Q

Duration of detemir/levemir

A
  • Intermediate acting
67
Q

Dose frequency and route of Detemir/Levemir

A
  • U-100 syringes

- BID SC with meals

68
Q

Other considerations for detemir/levemir

A
  • Not generally used for cats
  • Do not shake the bottle - roll gently to mix
  • Refrigerate
69
Q

Glargine/Lantus

A
  • Human recombinant, insulin analog
70
Q

Glargine/lantus Indication

A
  • You use this a LOT with cats; insulin of choice for cats
71
Q

Duration of action of glargine/lantus

A
  • Potentially long acting (12-24hr)

- Usually start BID and some can go to SID

72
Q

Dose frequency and route of glargine/lantus

A
  • BID
  • SC with meals
  • Use U-100 syringes
73
Q

Other considerations for Glargine/Lantus

A
  • Vials good for up to 6 months in refrigerator
  • Pens good for 1 month unrefrigerated
  • Do not shake the bottle - roll gently to mix
74
Q

Glargine/Lantus Bonus for cats

A
  • Can put them into remission potentially
75
Q

ProZinc

A
  • PZI insulin, Human recombinant
76
Q

ProZinc Indication

A
  • Often 2nd line choice after glargine for cats

- FDA approved for cats

77
Q

ProZinc Dose Frequency and syringe type

A
  • U40
  • BID
  • SC with meals
78
Q

Other considerations for ProZinc

A
  • Refrigerate
  • Do not shake the bottle
  • Roll gently to mix
79
Q

Treatment overview for Hypercalcemia

A
  • 1st: address and treat underlying cause if possible

- 2nd: provide non-specific therapy if no cause is found or can be treated

80
Q

Physiologic saline Diuresis overview

A
  • Non-specific
  • Fast and easy to do
  • Corrects dehydration, improves GFR, and improves hypercalcemia
81
Q

MOA of Physiologic Saline Diuresis

A
  • Corrects dehydration if present
  • Dehydration reduces GFR
  • Causes hemoconcentration which increases relative calcium plasma concentrations
  • Also decreases renal tubular calcium reabsorption as more calcium is excreted or lost
82
Q

Considerations for physiologic Saline Diuresis and Rate of action

A
  • Give IV or SC

- Fast acting

83
Q

Furosemide for Hypercalcemia Site of action

A
  • Loop of Henle
84
Q

Furosemide for Hypercalcemia MOA

A
  • Inhibits Na+/K+/2Cl- symporter

- Inhibits calcium reabsorption in the thick ascending limb of Loop of Henle

85
Q

Furosemide for Hypercalcemia Dose requirements

A
  • Animal must be hydrated/volume expanded prior to use
86
Q

Furosemide for Hypercalcemia Rate of action

A
  • VERY fast acting
87
Q

Glucocorticoids for hypercalcemia

A
  • Prednisone/Prednisolone

- Dexamethasone

88
Q

Glucocorticoids MOA

A
  • Reduce bone resorption of calcium
  • Increase renal calcium excretion
  • Decrease intestinal absorption of calcium
  • Cytotoxic to neoplastic lymphocytes (USE for lymphoma)
89
Q

Other considerations for glucocorticoids

A
  • Delay use of this drug until a diagnosis of lymphoma has been established or ruled out
  • Not very effective in patients with primary hyperparathyroidism or non-hematologic neoplasias
  • Depending on underlying cause may be fast acting
90
Q

Alendronate or Pamidronate, Zoledronate drug type

A
  • Bisphosphonates

- Alendronate is oral and the other two are injectable

91
Q

MOA of Alendronate or Pamidronate, Zoledronate

A
  • Inhibits osteoclast activity and bone resorption

- Promotes apoptosis and inhibits osteoclastogenesis, angiogenesis, and cancer cell proliferation

92
Q

Speed of Alendronate or Pamidronate, Zoledronate

A
  • Generally slow acting
93
Q

Alendronate Dose Intervals

A
  • For dog is SID

- For cat is once a week

94
Q

Adverse effects of Alendronate

A
  • GI signs

- Esophagitis

95
Q

Considerations for Alendronate

A
  • Fast 12 hrs before and 2 hrs after as food reduces absorption
  • Esophagitis: follow with water, butter the lips (cat), exercise for 30 min after (dogs)
96
Q

Pamidronate Dosing and route

A
  • IV diluted and given as CRI every 5-28 days
97
Q

Pamidronate Adverse effects

A
  • Electrolyte abnormalities (hypomagnesemia)

- Renal toxicity

98
Q

Considerations for pamidromate

A
  • Give over 2-4 hours to reduce renal effects
99
Q

Zoledronate dosing

A
  • Dilute and give as IV CRI over 15 min every 28 days
100
Q

Zoledronate adverse effects

A
  • Possible renal toxicity, but lower potential than with pamidronate
101
Q

Calcitonin origin

A
  • Salmon
102
Q

Calcitonin MOA

A
  • Inhibits osteoclastic bone resorption

- Reduces tubular reabsorption and promotes excretion of calcium, phosphorus, and other electrolytes

103
Q

Calcitonin usage in general

A
  • Not recommended
  • Dogs only
  • SC 2-3x a day
104
Q

Adverse effects of Calcitonin

A
  • GI, hypersensitivity
105
Q

Drug interactions with Calcitonin

A
  • Pamidronate

- No benefit and may worsen outcomes in dogs

106
Q

Other Considerations of Calcitonin

A
  • Very short duration of action, poor efficacy, expensive, development of resistance
107
Q

Hypocalcemia emergency treatment

A
  • Calcium gluconate 10% solution

- Calcium salt

108
Q

MOA of Calcium gluconate

A
  • Direct replacement
109
Q

Dosing instructions for Calcium Gluconate

A
  • Based on elemental calcium (contains 9.3 mg/mL)
  • SQ - dilute in equal volumes of saline
  • Must administer very slowly!!! ****
110
Q

Adverse effects of calcium gluconate 10% solution

A
  • Hypotension
  • Cardiac arrhythmias or arrest
  • SQ or IM administration could result in mild to severe tissue reactions
111
Q

Other considerations of calcium gluconate

A
  • Always check the formulation being used and dose off of elemental calcium content
  • monitor patients with an ECG during administration
112
Q

Chronic hypocalcemia cause

A
  • Most common cause is hypoparathyroidism

- lack of PTH production

113
Q

Absence of PTH

A
  • Vitamin D is not activated in kidneys

- Intestinal absorption, bone release, and renal retention of calcium are reduced

114
Q
  • Chronic hypocalcemia general principles
A
  • Generally combines a direct calcium supplement and vitamin D supplement
115
Q

Calcium carbonate

A
  • Tums
116
Q

MOA calcium carbonate

A
  • Direct replacement of calcium

- Also binds dietary phosphate

117
Q

Route of calcium carbonate

A
  • orally
118
Q

Considerations with Calcium Carbonate

A
  • Give with food
119
Q

Calcitriol

A
  • 1,25 dihydroxy vitamin D
  • Activated vitamin D
  • You need calcitriol to get oral calcium
120
Q

MOA of calcitriol

A
  • Vitamin D analog - direct replacement
121
Q

Indications of use for calcitriol

A
  • Hypoparathyroidism

- Renal secondary hyperparathyroidism (decreased renal activation of Vitamin D)

122
Q

Adverse effects of calcitriol

A
  • Hypercalcemia
  • Tissue mineralization
  • DO NOT give in hyperphosphatemic animals or those with Ca/Phos products >70 (Ca x Phos)
  • Development of calcium oxalate uroliths
123
Q

Other considerations of calcitriol

A
  • Combine with oral calcium supplementations to reduce dose needs